Latest data and clinical guidance
The cardiovascular metabolism (CVM) Learning Zone hosted on Medthority.com features over 70 expert opinion videos covering type 2 diabetes and hypertension.
The Association of British Neurologists releases its 2025 update on managing autoimmune myasthenia gravis. The guideline highlights daily steroid use, early thymectomy, expanded evidence for rituximab, and emerging roles for targeted therapies.
Israel publishes updated national guidelines for the diagnosis, treatment, and long‑term management of myasthenia gravis. The guidance standardizes diagnostic workup, antibody‑based treatment strategies, thymectomy timing, and care for special populations to reduce practice variability and improve outcomes.
The Portuguese Neuromuscular Society publishes consensus guidelines on the diagnosis and treatment of myasthenia gravis. The guidance provides step‑by‑step diagnostic workup, antibody‑based classification, and tailored treatment algorithms incorporating newer targeted therapies.
Experts from Saudi Arabia and the Gulf Cooperation Council present consensus guidelines to support the diagnosis and management of myasthenia gravis. Using the Delphi method, the recommendations aim to guide clinical decision‑making and improve outcomes by addressing regional needs and practice gaps.
The European Association of Urology (EAU) Urological Infections Guidelines Panel has compiled these clinical guidelines to provide medical professionals with evidence-based information and recommendations for...
The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected.
The 2018 ESC/EACTS Guidelines on myocardial revascularization provide comprehensive, evidence-based recommendations for patient-centered practice in myocardial revascularization. These guidelines integrate insights from cardiologists and cardiac surgeons to enhance treatment decisions.
Read the latest updates related to clinical trials and guidelines for prostate cancer, free for healthcare professionals.